KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Travere Therapeutics (TVTX) Goodwill (2016 - 2025)

Travere Therapeutics' Goodwill history spans 12 years, with the latest figure at $800000.0 for Q3 2025.

  • For Q3 2025, Goodwill changed 0.0% year-over-year to $800000.0; the TTM value through Sep 2025 reached $800000.0, changed 0.0%, while the annual FY2024 figure was $800000.0, 0.0% changed from the prior year.
  • Goodwill reached $800000.0 in Q3 2025 per TVTX's latest filing, roughly flat from $800000.0 in the prior quarter.
  • In the past five years, Goodwill ranged from a high of $936000.0 in Q1 2021 to a low of $800000.0 in Q4 2022.
  • Average Goodwill over 5 years is $853052.6, with a median of $800000.0 recorded in 2022.
  • Peak YoY movement for Goodwill: changed 0.0% in 2021, then dropped 11.11% in 2022.
  • A 5-year view of Goodwill shows it stood at $900000.0 in 2021, then fell by 11.11% to $800000.0 in 2022, then changed by 0.0% to $800000.0 in 2023, then changed by 0.0% to $800000.0 in 2024, then changed by 0.0% to $800000.0 in 2025.
  • Per Business Quant, the three most recent readings for TVTX's Goodwill are $800000.0 (Q3 2025), $800000.0 (Q2 2025), and $800000.0 (Q1 2025).